We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.7B
AUM Growth
+$2.29B
Cap. Flow
+$341M
Cap. Flow %
1.23%
Top 10 Hldgs %
18.59%
Holding
1,249
New
118
Increased
427
Reduced
427
Closed
119

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$113M
2
AAPL icon
Apple
AAPL
+$69M
3
PFE icon
Pfizer
PFE
+$57M
4
VZ icon
Verizon
VZ
+$50.4M
5
MSFT icon
Microsoft
MSFT
+$48.6M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$100M
2
LIN icon
Linde
LIN
+$85.1M
3
ABMD
Abiomed Inc
ABMD
+$55.4M
4
RACE icon
Ferrari
RACE
+$51.7M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 27.12%
2 Healthcare 20.97%
3 Financials 10.86%
4 Consumer Discretionary 10.19%
5 Industrials 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BG icon
301
Bunge Global
BG
$23.4B
$19.7M 0.07%
197,649
+18,773
+10% +$1.8M
IONS icon
302
Ionis Pharmaceuticals
IONS
$7.85B
$19.7M 0.07%
521,570
+339,214
+186% +$14.3M
COLD icon
303
Americold
COLD
$4.28B
$19.6M 0.07%
693,554
+123,551
+22% +$3.32M
FNV icon
304
Franco-Nevada
FNV
$50.7B
$19.6M 0.07%
143,541
-24,709
-15% -$3.26M
DOC
305
DELISTED
PHYSICIANS REALTY TRUST
DOC
$19.6M 0.07%
1,351,644
-1,549
-0.1% -$22.5K
EA
306
DELISTED
Electronic Arts
EA
$19.6M 0.07%
160,031
+82,562
+107% +$10.4M
SNA icon
307
Snap-on
SNA
$19.4B
$19.6M 0.07%
85,571
-16,687
-16% -$3.77M
ACGL icon
308
Arch Capital
ACGL
$33.1B
$19.5M 0.07%
310,146
+85,261
+38% +$4.76M
OTIS icon
309
Otis Worldwide
OTIS
$26.1B
$19.4M 0.07%
247,616
+95,930
+63% +$7.08M
CMA
310
DELISTED
Comerica
CMA
$19.2M 0.07%
286,600
+85,200
+42% +$5.9M
HES
311
DELISTED
Hess
HES
$19.1M 0.07%
134,373
+40,659
+43% +$5.59M
LH icon
312
Labcorp
LH
$26.3B
$19M 0.07%
93,785
-21,931
-19% -$4.29M
HPE icon
313
Hewlett Packard
HPE
$74.2B
$18.7M 0.07%
1,173,910
-945,833
-45% -$13.9M
PAYX icon
314
Paychex
PAYX
$42.1B
$18.6M 0.07%
160,811
-75,241
-32% -$8.81M
AFL icon
315
Aflac
AFL
$58.9B
$18.5M 0.07%
257,332
+16,354
+7% +$1.09M
MIRM icon
316
Mirum Pharmaceuticals
MIRM
$6.1B
$18.5M 0.07%
946,538
+88,327
+10% +$1.75M
BNY
317
Bank of New York Mellon
BNY
$105B
$18.3M 0.07%
402,682
-30,314
-7% -$1.3M
DXC icon
318
DXC Technology
DXC
$1.92B
$18.3M 0.07%
691,000
+120,600
+21% +$3.35M
UDR icon
319
UDR
UDR
$11.2B
$18.3M 0.07%
471,588
-4,810
-1% -$190K
LRCX icon
320
Lam Research
LRCX
$339B
$18.1M 0.07%
430,390
-76,520
-15% -$3.2M
WY icon
321
Weyerhaeuser
WY
$16.1B
$18M 0.07%
581,040
+33,391
+6% +$1.03M
FAST icon
322
Fastenal
FAST
$56.7B
$17.8M 0.06%
752,172
-309,796
-29% -$7.57M
RCL icon
323
Royal Caribbean
RCL
$66.7B
$17.7M 0.06%
358,694
-3,296
-0.9% -$173K
TRV icon
324
Travelers Companies
TRV
$78.8B
$17.5M 0.06%
93,117
-43,283
-32% -$7.79M
HPQ icon
325
HP
HPQ
$30.5B
$17.3M 0.06%
645,271
+177,731
+38% +$4.92M

Similar funds

Axa's Q4 2022 Portfolio in Review

As of Q4 2022, Axa held 1,249 positions worth $27.7B, up 9% from $25.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2022 filing shows 118 new, 427 increased, 427 reduced and 119 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M. The largest sale was Oracle, an estimated $100M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2022 buy was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M.
  • Axa added most to Tesla in Q4 2022, an estimated $113M increase.
  • Axa's biggest Q4 2022 reduction was Oracle, cutting an estimated $100M.
  • Axa fully exited Abiomed Inc in Q4 2022, selling an estimated $55.4M.
  • Axa's ten largest holdings make up 19% of its $27.7B portfolio in Q4 2022.
  • Axa opened 118 new positions and closed 119 in Q4 2022.
  • Axa's portfolio value rose 9% quarter-over-quarter to $27.7B.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.